Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|December 3, 2021
Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIVSamuel S Bailin, Suman Kundu, Melissa Wellons, et al.
Diabetes, Obesity & Metabolism|October 28, 2022
Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trialMona Mashayekhi, Joshua A Beckman, Hui Nian, et al.
Frontiers in Immunology|September 15, 2023
Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIVSamuel S Bailin, Jonathan A Kropski, Rama D Gangula, et al.
Open Forum Infectious Diseases|December 1, 2025
Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral TherapyTodd Hulgan, Kristine M Erlandson, Yuki Bradford, et al.
BMC Medicine|January 30, 2015
Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial, Suzanne Filteau, George PrayGod, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Adipose tissue as a site of immune activation and dysfunction in individuals with obesity and asthmaDawn C Newcomb, Alessandra Tomasello, Jean-Philippe Cartailler, et al.
The Journal of Infectious Diseases|June 9, 2025
Mitochondrial DNA Haplogroups, Biomarkers of Inflammation and Immune Activation, and Risk of Diabetes in Veterans With and Without Human Immunodeficiency VirusAiwei Yan, Suman Kundu, David C Samuels, et al.
Plos One|May 27, 2010
Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort studyDouglas C Heimburger, John R Koethe, Christopher Nyirenda, et al.
Mbio|February 24, 2021
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment InterruptionLeila B Giron, Emmanouil Papasavvas, Xiangfan Yin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2026
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)John R Koethe, Jordan E Lake, Amy Kantor, et al.
Pageof 17